Condition 1: Cardiotoxicity. Condition 2: Cardiac rehabilitation. Condition 3: Breast Cancer. Cardiomyopathy due to drug and external agent Therapeutic (nonsurgical) and rehabilitative cardiovascular devices associated with adverse incidents Malignant neoplasm of breast
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Breast Cancer patients Age < 65y Second phase of rehabilitation Without Cardiac diseaes before Cancer Treatment Treatment Drug: Anthracyclines 40 =Ejection Fraction= 50 Heart failure treatment: Beta blockers, ACEI Permission of Cardiologist Signature of consent letter
Exclusion criteria
Exclusion criteria: Conditions that cause the patient, not be able to perform the exercises(Fracture of limbs, pregnancy,…) Symptoms of severe heart failure Sign of recurrence of breast cancer (repeat chemotherapy)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cardiovascular function. Timepoint: before intervention and after 12 weeks after intervention. Method of measurement: echocardiography. | — |
Secondary
| Measure | Time frame |
|---|---|
| New York Heart Association (NYHA) Functional Classification. Timepoint: before and after 12 weeks intervention. Method of measurement: the New York Heart Association (NYHA) Functional Classification. It places patients in one of four categories based on how much they are limited during physical activity. | — |
Countries
Iran (Islamic Republic of)
Contacts
Islamic Azad University